usa intends to order relenza confirmed, page-50

Tooluck

There are references in recent analyst reports on the Biota site indicating that this was likely to happen. There are also references on the Glaxo website that this was happening.

Here is an October 2010 statement by Statement by
Assistant Secretary for Preparedness and Response
RADM, U.S. Public Health Service
U.S. Department of Health and Human Services (HHS)

http://www.hhs.gov/asl/testify/2009/10/t20091027a.html

"We know that antiviral resistance is a threat. So our acquisition strategy for additional antivirals needed to be flexible. A lesson learned from the 2009 H1N1 outbreak is that H1N1 is Tamiflu resistant, in rare cases. As a result, ASPR has increased efforts to stockpile an alternative antiviral, Relenza".

This rebalance is starting to happen as is already evidenced by these recent orders by the US Dept of Homeland Security.

There have also been very recent statements by WHO regarding complaints about the way authorities have dealt with the pandemic, "the Council of Europe, a political forum of most European countries, is to determine whether drug companies influenced public health officials to spend money unnecessarily on stockpiles of H1N1 vaccines."

It is clear that governments have overstocked on vaccines (that are only effective for Swine Flu), so it follows that strategies to increase stocks of Antivirals will be put in place - there is no alternative approach that I can think of.